Home LiteratureArticle Details
PMID: 12634372 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.

Journal of virology ·Vol. 77 ·No. 7 ·2003-04-00 ·Pages 4139-48

Chen H, Hutt-Fletcher L, Cao L, Hayward SD

Abstract

STAT3 and STAT5 are constitutively activated and nuclear in nasopharyngeal carcinoma (NPC) cells. In normal signaling, STATs are only transiently activated. To investigate whether Epstein-Barr virus (EBV), and in particular the protein LMP1, contributes to sustained STAT phosphorylation and activation in epithelial cells, we examined STAT activity in two sets of paired cell lines, HeLa, an EBV-converted HeLa cell line, HeLa-Bx1, the NPC-derived cell line CNE2-LNSX, and an LMP1-expressing derivative, CNE2-LMP1. EBV infection was associated with a significant increase in the tyrosine-phosphorylated forms of STAT3 and STAT5 in HeLa-Bx1 cells. This effect correlated with LMP1 expression, since phosphorylated STAT3 and STAT5 levels were also increased in CNE2-LMP1 cells relative to the control CNE2-LNSX cells. No change was observed in STAT1 or STAT6 phosphorylation in these cell lines, nor was there a significant change in the levels of total STAT3, STAT5, STAT1, or STAT6 protein. Tyrosine phosphorylation allows the normally cytoplasmic STAT proteins to enter the nucleus and bind to their recognition sequences in responsive promoters. The ability of LMP1 to activate STAT3 was further established by immunofluorescence assays in which coexpression of LMP1 in transfected cells was sufficient to mediate nuclear relocalization of Flag-STAT3 and by an electrophoretic mobility shift assay which showed that LMP1 expression in CNE2-LNSX cells was associated with increased endogenous STAT3 DNA binding activity. In addition, the activity of a downstream target of STAT3, c-Myc, was upregulated in HeLa-Bx1 and CNE2-LMP1 cells. A linkage was established between interleukin-6 (IL-6)- and LMP1-mediated STAT3 activation. Treatment with IL-6 increased phosphorylated STAT3 levels in CNE2-LNSX cells, and conversely, treatment of CNE2-LMP1 cells with IL-6 neutralizing antibody ablated STAT3 activation and c-Myc upregulation. The previous observation that STAT3 activated the LMP1 terminal repeat promoter in reporter assays was extended to show upregulated expression of endogenous LMP1 mRNA and protein in HeLa-Bx1 cells transfected with a constitutively activated STAT3. A model is proposed in which EBV infection of an epithelial cell containing activated STATs would permit LMP1 expression. This in turn would establish a positive feedback loop of IL-6-induced STAT activation, LMP1 and Qp-EBNA1 expression, and viral genome persistence.

MeSH Terms
Active Transport, Cell Nucleus Cell Line DNA-Binding Proteins/genetics,metabolism Epithelial Cells/metabolism,virology Feedback Gene Expression Regulation, Viral Genes, Viral HeLa Cells Herpesvirus 4, Human/genetics,metabolism,pathogenicity Homeostasis Humans Interleukin-6/antagonists & inhibitors,metabolism Milk Proteins Models, Biological Phosphorylation Recombinant Proteins/metabolism STAT3 Transcription Factor STAT5 Transcription Factor Signal Transduction Trans-Activators/genetics,metabolism Transfection Viral Matrix Proteins/genetics,metabolism
Chemicals
DNA-Binding Proteins EBV-associated membrane antigen, Epstein-Barr virus Interleukin-6 Milk Proteins Recombinant Proteins STAT3 Transcription Factor STAT3 protein, human STAT5 Transcription Factor Trans-Activators Viral Matrix Proteins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Chen Honglin
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland 21231, USA.
Hutt-Fletcher Lindsey
Cao Liang
Hayward S Diane
References (90)
90 references, click to expand
  1. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2.
    J Virol. 2000 Feb;74(4):1727-35 PMID: 10644343
  2. A role for SKIP in EBNA2 activation of CBF1-repressed promoters.
    J Virol. 2000 Feb;74(4):1939-47 PMID: 10644367
  3. LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression.
    Oncogene. 2000 Apr 13;19(16):2002-13 PMID: 10803461
  4. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    J Virol. 2000 Jun;74(11):5151-60 PMID: 10799590
  5. STATs in oncogenesis.
    Oncogene. 2000 May 15;19(21):2474-88 PMID: 10851046
  6. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.
    Oncogene. 2000 May 15;19(21):2548-56 PMID: 10851053
  7. Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells.
    J Virol. 2000 Jul;74(14):6324-32 PMID: 10864642
  8. The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.
    J Virol. 2000 Jul;74(14):6652-8 PMID: 10864681
  9. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
    Virology. 2001 Feb 15;280(2):183-98 PMID: 11162833
  10. Linkage between STAT regulation and Epstein-Barr virus gene expression in tumors.
    J Virol. 2001 Mar;75(6):2929-37 PMID: 11222718
  11. STAT proteins: novel molecular targets for cancer drug discovery.
    Oncogene. 2000 Dec 27;19(56):6613-26 PMID: 11426647
  12. STAT3 is constitutively activated in Hodgkin cell lines.
    Blood. 2001 Aug 1;98(3):762-70 PMID: 11468177
  13. Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.
    J Biol Chem. 2001 Nov 30;276(48):45443-55 PMID: 11579100
  14. Signalling downstream of activated mammalian Notch.
    Nature. 1995 Sep 28;377(6547):355-8 PMID: 7566092
  15. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.
    Mol Cell Biol. 1996 Mar;16(3):952-9 PMID: 8622698
  16. Frequent expression of interleukin-10 by Epstein-Barr virus-harboring tumor cells of Hodgkin's disease.
    Blood. 1996 Apr 1;87(7):2918-29 PMID: 8639912
  17. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia.
    Oncogene. 1996 Jul 18;13(2):247-54 PMID: 8710363
  18. Requirements for interleukin-4-induced gene expression and functional characterization of Stat6.
    Mol Cell Biol. 1996 Oct;16(10):5811-20 PMID: 8816495
  19. Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines.
    Cancer Res. 1996 Oct 15;56(20):4610-3 PMID: 8840972
  20. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Mol Cell Biol. 1996 Dec;16(12):7098-108 PMID: 8943365
  21. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
    Oncogene. 1996 Nov 21;13(10):2243-54 PMID: 8950992
  22. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.
    J Virol. 1996 Dec;70(12):8653-9 PMID: 8970991
  23. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Oncogene. 1997 Jun 19;14(24):2899-916 PMID: 9205097
  24. Modulation of interleukin-6 expression in Hodgkin and Reed-Sternberg cells by Epstein-Barr virus.
    J Pathol. 1997 Jul;182(3):299-306 PMID: 9349232
  25. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB.
    Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12592-7 PMID: 9356494
  26. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.
    EMBO J. 1997 Nov 3;16(21):6478-85 PMID: 9351829
  27. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
    J Virol. 1998 Feb;72(2):1365-76 PMID: 9445037
  28. Stat3 activation by Src induces specific gene regulation and is required for cell transformation.
    Mol Cell Biol. 1998 May;18(5):2545-52 PMID: 9566874
  29. Stat3 activation is required for cellular transformation by v-src.
    Mol Cell Biol. 1998 May;18(5):2553-8 PMID: 9566875
  30. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
    J Immunol. 1998 Feb 1;160(3):1116-21 PMID: 9570524
  31. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Oncogene. 1998 Apr 9;16(14):1869-77 PMID: 9583684
  32. Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbeta.
    Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10106-11 PMID: 9707608
  33. STAT3 is required for the gp130-mediated full activation of the c-myc gene.
    J Exp Med. 1999 Jan 4;189(1):63-73 PMID: 9874564
  34. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    J Virol. 1999 Feb;73(2):1023-35 PMID: 9882303
  35. Cutting edge: protective effects of notch-1 on TCR-induced apoptosis.
    J Immunol. 1999 Jan 15;162(2):635-8 PMID: 9916679
  36. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
    Immunity. 1999 Jan;10(1):105-15 PMID: 10023775
  37. Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1.
    Blood. 1999 Mar 1;93(5):1456-63 PMID: 10029571
  38. Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.
    J Virol. 1999 Apr;73(4):2983-93 PMID: 10074148
  39. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis.
    J Exp Med. 1999 Apr 19;189(8):1229-42 PMID: 10209040
  40. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    J Virol. 2002 Jan;76(1):232-42 PMID: 11739688
  41. The Epstein-Barr virus latent membrane protein 1 putative Janus kinase 3 (JAK3) binding domain does not mediate JAK3 association or activation in B-lymphoma or lymphoblastoid cell lines.
    J Virol. 2002 Jan;76(1):455-9 PMID: 11739714
  42. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.
    Clin Cancer Res. 2002 Apr;8(4):945-54 PMID: 11948098
  43. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
    Oncogene. 2002 Mar 27;21(13):2000-8 PMID: 11960372
  44. Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.
    Cell. 2002 Apr;109 Suppl:S121-31 PMID: 11983158
  45. Series introduction. JAK-STAT signaling in human disease.
    J Clin Invest. 2002 May;109(9):1133-7 PMID: 11994400
  46. Signaling through the JAK/STAT pathway, recent advances and future challenges.
    Gene. 2002 Feb 20;285(1-2):1-24 PMID: 12039028
  47. Smart drugs: tyrosine kinase inhibitors in cancer therapy.
    Cancer Cell. 2002 Mar;1(2):117-23 PMID: 12086869
  48. The role of interleukin 13 in classical Hodgkin lymphoma.
    Leuk Lymphoma. 2002 Jun;43(6):1203-10 PMID: 12152987
  49. Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis.
    Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11878-83 PMID: 12195020
  50. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Nat Med. 2002 Oct;8(10):1098-104 PMID: 12219084
  51. Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma.
    Int J Cancer. 1983 May 15;31(5):587-90 PMID: 6852976
  52. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
    Arch Otorhinolaryngol. 1984;239(1):87-92 PMID: 6318711
  53. Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells.
    J Virol. 1985 Sep;55(3):710-20 PMID: 2991591
  54. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.
    Cell. 1985 Dec;43(3 Pt 2):831-40 PMID: 3000618
  55. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
    J Virol. 1990 Jun;64(6):3033-41 PMID: 2159561
  56. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    J Virol. 1990 Jul;64(7):3407-16 PMID: 2352328
  57. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    J Virol. 1991 May;65(5):2164-9 PMID: 1850003
  58. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  59. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.
    Cell. 1991 Jun 28;65(7):1107-15 PMID: 1648447
  60. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    J Virol. 1991 Dec;65(12):6765-71 PMID: 1658373
  61. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
    J Virol. 1992 May;66(5):2846-52 PMID: 1313905
  62. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.
    J Virol. 1992 Nov;66(11):6496-501 PMID: 1404600
  63. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B.
    J Biol Chem. 1992 Dec 5;267(34):24157-60 PMID: 1332946
  64. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    EMBO J. 1993 Jan;12(1):167-75 PMID: 8381349
  65. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.
    Science. 1994 Jul 1;265(5168):92-5 PMID: 8016657
  66. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.
    Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7568-72 PMID: 8052621
  67. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
    J Virol. 1994 Nov;68(11):6947-58 PMID: 7933076
  68. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless.
    EMBO J. 1994 Oct 17;13(20):4973-82 PMID: 7957063
  69. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    J Virol. 1995 Jan;69(1):253-62 PMID: 7983717
  70. The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
    EMBO J. 1994 Dec 1;13(23):5624-32 PMID: 7988559
  71. The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.
    EMBO J. 1994 Dec 1;13(23):5633-8 PMID: 7988560
  72. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Oncogene. 1995 Feb 2;10(3):549-60 PMID: 7845680
  73. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family.
    Cell. 1995 Feb 10;80(3):389-99 PMID: 7859281
  74. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.
    J Virol. 1995 May;69(5):2968-76 PMID: 7707523
  75. Masking of the CBF1/RBPJ kappa transcriptional repression domain by Epstein-Barr virus EBNA2.
    Science. 1995 Apr 28;268(5210):560-3 PMID: 7725102
  76. The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat.
    J Virol. 1995 Jul;69(7):4577-81 PMID: 7769727
  77. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.
    Science. 1995 Jul 7;269(5220):81-3 PMID: 7541555
  78. Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood.
    Blood. 1999 May 1;93(9):3026-32 PMID: 10216099
  79. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.
    J Biol Chem. 1999 Jun 4;274(23):16085-96 PMID: 10347160
  80. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins.
    EMBO J. 1999 Jun 1;18(11):3064-73 PMID: 10357818
  81. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.
    Mol Cell Biol. 1999 Aug;19(8):5759-67 PMID: 10409763
  82. STAT5 activation by BCR-Abl contributes to transformation of K562 leukemia cells.
    Blood. 1999 Aug 1;94(3):1108-12 PMID: 10419904
  83. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9339-44 PMID: 10430944
  84. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus.
    Int J Cancer. 1999 Sep 24;83(1):121-6 PMID: 10449618
  85. Stat3 as an oncogene.
    Cell. 1999 Aug 6;98(3):295-303 PMID: 10458605
  86. IFN-alpha activates Stat6 and leads to the formation of Stat2:Stat6 complexes in B cells.
    J Immunol. 1999 Oct 1;163(7):3834-41 PMID: 10490982
  87. Additive effect of Sp1 and Sp3 in regulation of the ED-L1E promoter of the EBV LMP 1 gene in human epithelial cells.
    Virology. 1999 Sep 1;261(2):288-94 PMID: 10497114
  88. Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses.
    Science. 1999 Oct 8;286(5438):300-3 PMID: 10514374
  89. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4 PMID: 8415670
  90. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 PMID: 8415684
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2003-04-00
Pages
4139-48
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC150666
Subset
IM
Grants
NIAID NIH HHS · R01 AI020662 · United States
NCI NIH HHS · R01 CA030356 · United States
NIAID NIH HHS · R01 AI20662 · United States
NCI NIH HHS · R01 CA30356 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]